Skip to main content

TCGX · TCGX Acquisition Corp.

Track TCGX — free
$10.01 -0.01 (-0.10%)
Market Cap
$113.26M
Shares
11.30M
Volume · Oct 20 1.08M Avg daily vol (52 sessions) 124.3K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$10.01 Open$10.03 Day$10.00–10.11 Available close range$10.01–17.50 Avg vol 30d112K Short int53K · 0.5% float · 2.9d Short vol2% DataAug 2026–Oct 2026 Filing10-Q · Sep 10

The closing range uses available history since Aug 5, 2026; less than a full year is stored.

Up next

filed Sep 10, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$0
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.5%
Latest settlement · 2.9 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Limited Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 18.4 · elevated Equity put/call 0.55
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 50-day avg −27%
below
RSI (14) 30
neutral
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.47% of float · ▲ +21164.4% MoM · 2.9 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
No 13F holder history
Squeeze score 53
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 91%
annualized · 1-yr
Max drawdown −43%
past year
ATR 10.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−27% Bearish
RSI (14)
30 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.47% of float · ▲ +21164.4% MoM · 2.9 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
No 13F holder history
Price context
position in its available closing range
Range low $10 Now $10 · 0% Range high $18
vs 50-day avg -27%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Shell Companies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TCGX
TCGX Acquisition Corp.
this stock
$113.26M — — — 0.5%
VYLR
Vylor Inc.
$48.31B — — — —
CLUS
Cluster Group Holdings Ltd Co
$8.00B — — — —
DMII
Drugs Made In America Acquisition II Corp.
$648.15M +2.9% — — 0.2%
EVAC
EQV Ventures Acquisition Corp. II
$603.18M +2.9% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
53.2K
Days to cover
2.9d
Change
+52.9K sh
View
Short Volume
Short vol %
2%
As of
Oct 19, 2026
Short Total
View
Fails to Deliver
FTD shares
34
Value
$491
As of
Sep 25, 2026
View
Off-Exchange
Off-exchange %
14.9%
Week of
Sep 14, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 19, 2026
This year
6

TCGX Acquisition Corp. entered a Business Combination Agreement on October 18, 2026 with TriGemX Bio, Inc. (formerly Kallyope) to merge at a $361,000,000 pre-money equity value, with a $160,000,000 PIPE Financing, expected to close in Q1 2027.

View

Performance

5D 20D 120D MTD YTD
TCGX -19.0% -31.7% — -20.0% —
SPY -1.2% -0.6% +8.1% +0.8% +12.8%
vs SPY -17.9% -31.1% — -20.8% —
Key facts CIK 2137965 CUSIP G8708J109 Visit website